Complement as a target in COVID-19?
Complement as a target in COVID-19?
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.
This Comment article from Lambris and colleagues considers the therapeutic potential of targeting the complement system in patients with COVID-19.
Alternative Titles
Full title
Complement as a target in COVID-19?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7187144
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7187144
Other Identifiers
ISSN
1474-1733
E-ISSN
1474-1741
DOI
10.1038/s41577-020-0320-7
